Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO >

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	101.44

NSE Code	SUNPHARMA
Dividend Yield %	0.96
Market Cap	4008089.07

P/E	93.59
EPS	17.85
Face Value	1


	BSE		NSE

25-Jun-2025

Last Price	1670.50
Net Change	9.2
% Change	0.55%
Prev.Close	1661.30
Open	1667.85
High	1677.95
Low	1660.20
Volume	68293

Last Price	1669.60
Net Change	7.9
% Change	0.48%
Prev.Close	1661.70
Open	1661.70
High	1678.80
Low	1658.10
Volume	1372945

Value	114301650
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1677.95
52-Week High	1960.20
52-Week Low	1495.05

Value	2294093649.4
Best Buy	0.00
Best Sell	1669.60
Best Quantity	0
Sell Quantity	12
Today's Range	1678.80
52-Week High	1960.35
52-Week Low	1495.25

Open Price	1660.90
High Price	1679.00
Low Price	1657.40
Last Price	1670.20
Prev Close	1663.80
Change	6.40
% Change	0.38 %

Average Price	1673.10
Underlying Value	1669.60
Number of contracts traded	12281
Turnover in Rs. Lakhs	71916
Open Interest	3905650.00
Change in O I	-3558100.00
% Change in O I	-47.67 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	12
Price	1669.60

Best Bid

Best Offer

Quantity	350
Price	1668.8

Quantity	1050
Price	1671.4

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

25-06-2025

Sun Pharmaceutical Indus...

25-06-2025

Sun Pharma’s partner with...

25-06-2025

Sun Pharma gains on the B...

14-06-2025

USFDA conducts GMP inspec...

26-05-2025

Sun Pharmaceutical Indust...

23-05-2025

Sun Pharmaceutical Indust...

24-04-2025

Sun Pharmaceutical Indust...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.